Contract facts
NONENo full NAICS 541940 intel page yet. Browse NAICS intelligence
HISTOPATHOLOGY SERVICES TO SUPPORT 5 EFFICACY STUDIES STARTING WITH PREPARED SLIDES AND 5 STUDIES STARTING WITH FIXED TISSUES. OPTIONS FOR ADDITIONAL STUDIES STARTING WITH PREPARED SLIDES AS WELL AS STUDIES STARTING WITH FIXED TISSUES. is a federal NONE award for National Institutes Of Health Niaid held by Experimental Pathology Laboratories, Inc. Estimated value $804K ($130K obligated). Current period of performance ends Mar 24, 2027 (potential Sep 24, 2027). Last award drew 6 bidders. Place of performance: STERLING VA. Related solicitation RFQ-NIAID-24-2226993.
HISTOPATHOLOGY SERVICES TO SUPPORT 5 EFFICACY STUDIES STARTING WITH PREPARED SLIDES AND 5 STUDIES STARTING WITH FIXED TISSUES. OPTIONS FOR ADDITIONAL STUDIES STARTING WITH PREPARED SLIDES AS WELL AS STUDIES STARTING WITH FIXED TISSUES.
Recompete timing
PublicCurrent PoP ends Mar 24, 2027 (198 days remaining). Agencies typically plan 12–18 months ahead — at 6.5 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordExperimental Pathology Laboratories, Inc — $22.2M obligated across 18 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93024P01204?
75N93024P01204 (Histopathology services to support) is a National Institutes Of Health Niaid award with a potential value of $804K, currently held by Experimental Pathology Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93024P01204?
National Institutes Of Health Niaid awarded 75N93024P01204 to Experimental Pathology Laboratories, Inc (potential $804K).
Who is the incumbent on 75N93024P01204?
Experimental Pathology Laboratories, Inc is the incumbent with $22.2M across 18 related awards in SCOUT’s public footprint. The current period of performance ends Mar 24, 2027.
When does Experimental Pathology Laboratories, Inc’s 75N93024P01204 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 24, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 75N93024P01204 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.